These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7322296)

  • 1. Behavioural and neurochemical studies on apomorphine-induced hypomotility in mice.
    Sumners C; de Vries JB; Horn AS
    Neuropharmacology; 1981 Dec; 20(12A):1203-8. PubMed ID: 7322296
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible significance of clozapine-induced increase in brain dopamine.
    Gianutsos G; Moore KE
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):29-39. PubMed ID: 877404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.
    Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):167-76. PubMed ID: 181681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a putative antidepressant, an O2-substituted derivative of barbitone on apomorphine induced hypomotility.
    Menez JF; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(6):703-8. PubMed ID: 3809521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered response to apomorphine in 6-hydroxydopamine-treated rats.
    Schoenfeld R; Uretsky N
    Eur J Pharmacol; 1972 Jul; 19(1):115-8. PubMed ID: 5048659
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
    Carlsson A; Engel J; Strömbom U; Svensson TH; Waldeck B
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(2):117-28. PubMed ID: 4278296
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of catecholamines for the manifestation of morphine withdrawal in the rat].
    Bläsig J; Papeschi R; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1015-6. PubMed ID: 4408108
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1974 Apr; 26(1):41-50. PubMed ID: 4598755
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracerebroventricular apomorphine alleviates spontaneous forgetting and increases cortical noradrenaline.
    Sara SJ; Grecksch G; Leviel V
    Behav Brain Res; 1984 Jul; 13(1):43-52. PubMed ID: 6477718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics.
    Gianutsos G; Moore KE
    Psychopharmacology (Berl); 1977 May; 52(3):217-21. PubMed ID: 406622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of N,N dipropyl-8-hydroxy-3-chromanamine, an oxygen isostere of the dopamine agonist N,N dipropyl-5-hydroxy-2-aminotetralin with enhanced presynaptic selectivity.
    Vermue NA; Kaptein B; Tepper PG; de Vries JB; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():37-56. PubMed ID: 3421784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of continuous and acute administration of small doses of apomorphine, alone or in combination with chlorpromazine, on the brain monoamines and free amino acid levels in the rat.
    Koyuncuoğlu H; Atamer-Simşek S; Keyer-Uysal M
    Psychopharmacology (Berl); 1979 Nov; 66(2):171-7. PubMed ID: 119259
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacologia; 1973; 29(4):289-98. PubMed ID: 4707021
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.
    Martres MP; Costentin J; Baudry M; Marcais H; Protais P; Schwartz JC
    Brain Res; 1977 Nov; 136(2):319-37. PubMed ID: 922486
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nomifensine on motor activity, dopamine turnover rate and cyclic 3',5;-adenosine monophosphate concentrations of rat striatum.
    Gerhards HJ; Carenzi A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(1):49-63. PubMed ID: 4375258
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral concomitants of regional changes in the brain's biogenic amines after apomorphine and amphetamine.
    Schwarting RK; Huston JP
    Pharmacol Biochem Behav; 1992 Apr; 41(4):675-82. PubMed ID: 1594634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral correlates of dopaminergic supersensitivity.
    Iversen SD; Creese I
    Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.